Aarhus University Seal

Six researchers from Health receive millions of kroner from Lundbeck

More than DKK 12 million given to research projects at the Department of Clinical Medicine will, among other things, help us to learn more about the brain and its role in connection with physical and mental disorders. The research grants come from the Lundbeck Foundation and go to younger, promising researchers.

Six researchers from the Department of Clinical Medicine are among the recipients of the DKK 65.3 million awarded by the Lundbeck Foundation to a total of 32 postdoc projects. The foundation traditionally supports brain research, although other health science research projects have made it through the eye of the needle and will now receive a financial helping hand.

Lau Møller Andersen, postdoc, Department of Clinical Medicine, CFIN/MINDLab
Receives a grant of DKK 1,588,804 to conduct research into the role of the cerebellum in connection with Parkinson's disease.

Mikkel Petersen, postdoc, Department of Clinical Medicine, CFIN
Receives DKK 2,085,000 to develop an interactive 'hologram’ to be used for detailed planning of advanced brain surgeries, among other things.

Martin Dietz, postdoc, Department of Clinical Medicine, CFIN
Receives DKK 2,261,899 to investigate patterns of brain activity which may be related to the risk of developing schizophrenia.

Maryam Ardalan, postdoc, Department of Clinical Medicine, CFIN
Will utilise a research grant of DKK 2,331,820 to identify biomarkers for autism among prematurely born infants.

Jesper Falkesgaard Højen, PhD, postdoc from 2021, Department of Clinical Medicine
Will utilise the research grant of DKK 2,465,400 to study parts of the human immune system which, it is assumed, play an 'anonymous' but important role for our health.

Carin Lunenburg, postdoc, Department of Clinical Medicine
Receives DKK 1,599,950 towards her research project which focuses on expanding our understanding of how patient’s genetic conditions can have an influence on the effects of psychoactive drugs.

 

This coverage is partly based on press material from the Lundbeck Foundation.